General Information of Drug (ID: DMKMBES)

Drug Name
Plazomicin Drug Info
Synonyms ACHN-490; UNII-LYO9XZ250J; 1154757-24-0; LYO9XZ250J; Plazomicin [USAN:INN]; Plazomicin (USAN); ZINC68150640; DB12615; D10151; D-Streptamine,
Indication
Disease Entry ICD 11 Status REF
Bronchitis CA20 Approved [1]
Prostate disease GA91 Approved [1]
Urinary tract infection GC08 Approved [1]
Pancreatic cancer 2C10 Phase 3 [2]
Cross-matching ID
PubChem CID
42613186
CAS Number
CAS 1154757-24-0
TTD Drug ID
DMKMBES
INTEDE Drug ID
DR2136
ACDINA Drug ID
D01346

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Mitochondrial rRNA methyltransferase 2 (MRM2) TTUQ7WN MRM2_HUMAN Inhibitor [1]

Drug-Metabolizing Enzyme (DME)
DME Name DME ID UniProt ID MOA REF
Aminoglycoside O-phosphotransferase (aphA6) DESGYWE G9FRK8_PROST Substrate [3]
Aminoglycoside acetyltransferase (aac) DE69QHT AAC2_PROST Substrate [3]

References

1 In vitro activity of plazomicin against -lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE).J Antimicrob Chemother. 2017 Oct 1;72(10):2792-2795.
2 ClinicalTrials.gov (NCT01970371) A Study of Plazomicin Compared With Colistin in Patients With Infection Due to Carbapenem-Resistant Enterobacteriaceae (CRE). U.S. National Institutes of Health.
3 Plazomicin retains antibiotic activity against most aminoglycoside modifying enzymes. ACS Infect Dis. 2018 Jun 8;4(6):980-987.